These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31359423)

  • 41. Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: a comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide.
    Ki YJ; Park S; Ha SI; Choi DH; Song H
    Platelets; 2014; 25(6):427-32. PubMed ID: 24102424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between high-sensitivity cardiac troponin T and future cardiovascular incidence in a general Japanese population: results from the Tohoku medical megabank project.
    Takahashi Y; Satoh M; Ohmomo H; Tanaka F; Osaki T; Tanno K; Nasu T; Sakata K; Morino Y; Sobue K; Sasaki M
    Biomarkers; 2019 Sep; 24(6):566-573. PubMed ID: 30978115
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study.
    Nadruz W; Gonçalves A; Claggett B; Querejeta Roca G; Shah AM; Cheng S; Heiss G; Ballantyne CM; Solomon SD
    Eur J Heart Fail; 2016 Jun; 18(6):629-37. PubMed ID: 27030444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
    Apple FS; Murakami MM; Pearce LA; Herzog CA
    Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
    Berry JD; Chen H; Nambi V; Ambrosius WT; Ascher SB; Shlipak MG; Ix JH; Gupta R; Killeen A; Toto RD; Kitzman DW; Ballantyne CM; de Lemos JA
    Circulation; 2023 Jan; 147(4):310-323. PubMed ID: 36533535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac Biomarker Release after Endurance Exercise in Male and Female Adults and Adolescents.
    Legaz-Arrese A; Carranza-García LE; Navarro-Orocio R; Valadez-Lira A; Mayolas-Pi C; Munguía-Izquierdo D; Reverter-Masía J; George K
    J Pediatr; 2017 Dec; 191():96-102. PubMed ID: 29173327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: a prospective observational study.
    Aarsetøy R; Omland T; Røsjø H; Strand H; Lindner T; Aarsetøy H; Staines H; Nilsen DWT
    BMC Cardiovasc Disord; 2020 Aug; 20(1):382. PubMed ID: 32838754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.
    Lazo M; Rubin J; Clark JM; Coresh J; Schneider AL; Ndumele C; Hoogeveen RC; Ballantyne CM; Selvin E
    J Hepatol; 2015 Apr; 62(4):841-7. PubMed ID: 25433159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
    Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
    JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
    Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-terminal pro-brain natriuretic peptide and high-sensitivity troponin T exhibit additive prognostic value for the outcome of critically ill patients.
    Lenz M; Krychtiuk KA; Goliasch G; Distelmaier K; Wojta J; Heinz G; Speidl WS
    Eur Heart J Acute Cardiovasc Care; 2020 Aug; 9(5):496-503. PubMed ID: 29617154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
    Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
    J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Highly sensitive cardiac troponin T and long-term mortality in a population of community-derived perimenopausal women: nested case-control study.
    Cramer GE; Brouwer MA; Vader HL; de Boer MJ; Pop GA; Pop VJ; Verheugt FW
    Heart; 2013 Apr; 99(8):528-33. PubMed ID: 23315610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINT.
    Haney D; Ma Y; Dalmacy D; Pajewski NM; Hajjar I; de Lemos JA; Zhang W; Soliman EZ; Ballantyne CM; Nambi V; Sattar N; Killeen AA; Ix JH; Shlipak MG; Berry JD; Ascher SB
    Hypertension; 2024 Sep; 81(9):1956-1965. PubMed ID: 38957975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study).
    Garg PK; Norby FL; Wang W; Krishnappa D; Soliman EZ; Lutsey PL; Selvin E; Ballantyne CM; Alonso A; Chen LY
    Am J Cardiol; 2021 Nov; 158():45-52. PubMed ID: 34465464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study.
    Dallmeier D; Denkinger M; Peter R; Rapp K; Jaffe AS; Koenig W; Rothenbacher D;
    Clin Chem; 2015 Feb; 61(2):389-99. PubMed ID: 25501933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
    Folsom AR; Lutsey PL; Heckbert SR; Poudel K; Basu S; Hoogeveen RC; Cushman M; Ballantyne CM
    J Thromb Haemost; 2018 Oct; 16(10):1964-1972. PubMed ID: 30007116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score.
    Börekçi A; Gür M; Şeker T; Baykan AO; Özaltun B; Karakoyun S; Karakurt A; Türkoğlu C; Makça I; Çaylı M
    Perfusion; 2015 Sep; 30(6):457-64. PubMed ID: 25358476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.